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Q Fever in 
Woolsorters, 
Belgium
To the Editor: Recent outbreaks 
of Q fever in the Netherlands and 
the United Kingdom raised public 
awareness about this ubiquitous 
bacterial disease known for decades to 
circulate worldwide (1–4). The disease, 
which ranges from a self-recovering 
infl uenza-like illness to pneumonia 
and severe meningoencephalitis, 
myocarditis, or endocarditis, is usually 
transmitted from animals to humans 
by airborne particles derived from 
contaminated feces and birth products. 
Clinical symptoms develop in only 
≈40% of infected humans (1). In ≈1%–
2% of these persons, symptoms evolve 
toward the chronic form of the disease, 
which can be life-threatening (5).
Q fever seroprevalence in the 
general population in Europe ranges 
from 2.4% to >30% in some countries 
in the Mediterranean region (5). 
Despite improved awareness during 
the past 3 years and geographic 
proximity with the Netherlands, 
few human cases were reported in 
Belgium (14, 27, and 33 cases in 
2007, 2008, and 2009, respectively) 
(6). A retrospective survey of blood 
donors in the Netherlands showed 
a seroprevalence of 2.4% before 
the start of outbreaks (7). In France, 
the prevalence of the disease in the 
Nord-Pas-de-Calais region bordering 
Belgium is low and accounts for 
only 0.5% of Q fever cases in France 
(8). Seroprevalence of the general 
population in Belgium, although 
unknown, is thus probably comparable 
with that in neighboring countries 
in absence of outbreaks and is not 
expected to exceed 5%.
We report a serologic, epi-
demiologic, and microbiological Q 
fever survey conducted in a scouring 
factory that processed wool and goat 
hair products in Belgium. No acute 
Q fever episodes were previously 
reported by the factory workers. 
Data on clinical symptoms and risk 
factors were obtained in face-to-face 
interviews, and associations with 
seropositivity were explored by using 
regression analysis. Airborne dust 
collected inside the factory during 
goat hair processing (9) contained 
102–103 genome equivalents of 
Coxiella burnetii, the Q fever agent, 
per liter of air as estimated by real-
time PCR (Laboratoire Service 
International, Lissieu, France) 
(online Appendix Table, wwwnc.
cdc.gov/EID/article/17/12/10-1786-
TA1.htm). Sheep wool processing 
generated less dust and resulted in a 
C. burnetii air load that never reached 
10 genome equivalents/L in our 
analyses. No information is available 
about the infectivity or viability 
of air-suspended C. burnetii in the 
studied environment.
Q fever serologic analysis was 
conducted by using an in-house ELISA 
for serum samples from 69 workers 
obtained annually during 2007–2009. 
Results of samples from the third year 
were confi rmed in parallel by using an 
immunofl uorescent assay (IFA) (Focus 
Diagnostics, Cypress, CA, USA) in 
the reference laboratory in Belgium 
and with follow-up samples in cases 
of noninterpretable or suspected 
serologic profi les. The 3-year 
cumulative seroprevalence was 50.7% 
(Table). This high value likely results 
from occupational exposure inside the 
factory. However, one cannot exclude 
that characteristics such as traveling 
abroad, farming, or living near farm 
animals might account for part of the 
seroprevalence. Nevertheless, such 
characteristics could not be associated 
with positive serologic results in our 
epidemiologic analysis.
The serologic status of 2 workers 
(T3 and T42) was compatible with 
ongoing chronic Q fever as assessed by 
IFA and ELISA (Table). Another IFA 
conducted in the reference laboratory 
in France confi rmed a serologic status 
compatible with chronic Q fever for 
worker T3 and detected anti–phase I 
and II IgA in this worker. However, 
chronic status was not confi rmed for 
worker T42 by this laboratory (online 
Appendix Table).
Profi les of other workers in 
the cohort were characterized by 
increased anti–phase II IgG, IgM, or 
both (9/69, 13%) over a 2-year period. 
These profi les suggest relapse and may 
result from continuous exposure to the 
Q fever agent, which led to reinfection 
or repeated stimulation of the immune 
response. Molecular testing did not 
detect C. burnetii DNA in any blood 
sample, and clinical examinations 
did not detect endocarditis in worker 
T3 as analyzed by positron emission 
tomography and transthoracic and 
transesophagian echocardiography. 
However, infection of tissues other 
2368 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 12, December 2011








No. negative 29 27 34 
No. nonspecifically reactive NA 9 NA 
No. with past infection 31 31 26 
No. with recent or active infection 7 NA 8 
No. with chronic infection 2 2 1 
% Seroreactive 57.9 47.8 50.7 
*IFA, immunofluorescent assay; NA, not applicable. 
†Conducted on samples collected annually for 3 y. Serologic titer for chronic Q fever: phase I IgG 
>12,800 and > phase II IgG; for recent or active infection, phase II IgG >1,600 and phase II IgM 
>800; for past infections, phase II IgG >1,600 and phase II IgM <800. 
‡Conducted on paired samples in cases of suspected or noninterpretable initial results; conducted 
on single samples in all other cases. Serologic status was defined at year 3 according to the 
instructions of the test kit manufacturer (Focus Diagnostics, Cypress, CA, USA). 
§Workers with test results above the threshold at least once over a 3-y period by ELISA and IFA. 
Serologic status was adjusted on the basis of the 3-y projection and retesting in the reference 
laboratory in France.
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than the heart in this worker cannot be 
ruled out.
Our results indicate high 
seroprevalence of Q fever among 
workers at the scouring factory 
studied. Continuous exposure to the 
Q fever agent was the likely cause of 
atypical antibody responses evoking 
a chronic or relapsing disease in the 
absence of any clinical symptom. 
These results indicated the need to 
analyze paired serum samples and 
to rely on medical follow-up before 
establishing a defi nitive diagnosis.
Given the continuous occupational 
risk to which these workers are exposed, 
hiring of pregnant women or persons 
with underlying medical conditions, 
such as valvulopathy or immunologic 
depression, should be avoided. 
Moreover, annual serologic testing 
should be conducted on all exposed 
persons to detect any evolution toward 
the chronic form of the disease, which 
can be life-threatening. Although less 
dangerous than anthrax, Q fever is 
still a highly prevalent occupational 
disease that affects persons working 
with animal hairs in industrial 
environments and commonly referred 
to as woolsorters (10).
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Roe Deer during 
Q Fever Epidemic, 
the Netherlands
To the Editor: A Q fever 
epidemic among humans started in 
the Netherlands in 2007 and peaked 
in 2009 (1). Epidemiologic evidence 
linked the epidemic to abortions and 
deliveries among Coxiella burnetii–
infected dairy goats and dairy sheep 
(1,2). However, questions arose about 
whether C. burnetii infection in free-
living wildlife might be another source 
of Q fever in humans. C. burnetii 
has a wide host range (3), but to our 
knowledge no studies had addressed 
its occurrence in nondomestic animals 
in the Netherlands (4).
The main objective of this study 
was to look for evidence of C. burnetii 
infection in carcasses of free-living 
roe deer (Capreolus capreolus) in 
the Netherlands, where C. capreolus 
is the most common species of wild 
ruminant. Additional objectives were 
to 1) analyze characteristics, location, 
and time of death of case-animals for 
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